Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Pediatr ; 17(11): 1535-9, 2010 Nov.
Artigo em Francês | MEDLINE | ID: mdl-20850284

RESUMO

Acute inflammatory polyradiculoneuropathy, or Guillain-Barré syndrome (GBS), is characterized by peripheral nerve demyelination, which leads to rapidly progressive weakness, loss of sensation, and loss of deep tendon reflexes. It is a prototype of postinfectious autoimmune disease, whose pathophysiology is well described in the forms provoked by certain bacteria (molecular mimicry with Campylobacter jejuni), but remains unclear for the forms related to other organisms (cytomegalovirus, Epstein-Barr virus and other herpes group viruses, Mycoplasma pneumoniae). Glomerular lesions can be associated with the neurological symptoms and have also been described after various infections, independently of any signs of polyradiculoneuropathy. We report the observation of a 12-year-old girl who presented with Guillain-Barré syndrome with facial diplegia, ataxia, and intracranial hypertension following Epstein-Barr virus (EBV) primary infection. During the course of the neurological disease, membranous glomerulonephritis (MGN) was diagnosed. The neurological impairment was regressive within 6 months after intravenous immunoglobulin treatment followed by intravenous then oral corticosteroid administration. Viremia remained high more than 6 months after the onset of symptoms. Glomerulopathy progressed independently and finally required immunosuppressant medication with cyclosporine. EBV might be the factor that triggered the autoimmune disorders, as previously reported for systemic lupus erythematosus and multiple sclerosis in children. To the best of our knowledge, this association of 3 conditions (GBS, MGN, and EBV primary infection) has never been reported in the literature.


Assuntos
Infecções por Vírus Epstein-Barr/complicações , Glomerulonefrite Membranosa/virologia , Síndrome de Guillain-Barré/virologia , Herpesvirus Humano 4 , Ataxia/virologia , Criança , Ciclosporina/uso terapêutico , Quimioterapia Combinada , Infecções por Vírus Epstein-Barr/diagnóstico , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Infecções por Vírus Epstein-Barr/imunologia , Paralisia Facial/virologia , Feminino , Glomerulonefrite Membranosa/diagnóstico , Glomerulonefrite Membranosa/tratamento farmacológico , Glomerulonefrite Membranosa/imunologia , Glucocorticoides/uso terapêutico , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/tratamento farmacológico , Síndrome de Guillain-Barré/imunologia , Herpesvirus Humano 4/imunologia , Humanos , Imunoglobulinas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Imunossupressores/uso terapêutico , Hipertensão Intracraniana/virologia , Resultado do Tratamento
2.
Arch Pediatr ; 17(3): 325-32, 2010 Mar.
Artigo em Francês | MEDLINE | ID: mdl-20045298

RESUMO

Acute motor deficit is not uncommon in childhood, with various neurological etiologies. Pertinent semiological analysis allows correct diagnosis management, with adequate paraclinical investigations. The authors describe this clinical diagnosis strategy. The most common clinical situations and various etiologies are presented; paraclinical investigations confirming the diagnosis are discribed, with specific attention to central nervous system imaging according to the most recent sequences.


Assuntos
Transtornos dos Movimentos/etiologia , Doenças Neuromusculares/etiologia , Doença Aguda , Encefalopatias/diagnóstico , Encefalopatias/terapia , Isquemia Encefálica/diagnóstico , Isquemia Encefálica/terapia , Transtornos Cerebrovasculares/diagnóstico , Transtornos Cerebrovasculares/terapia , Criança , Diagnóstico Diferencial , Humanos , Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/terapia , Miosite/diagnóstico , Miosite/terapia , Doenças Neuromusculares/diagnóstico , Doenças Neuromusculares/terapia , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/terapia , Polirradiculoneuropatia/diagnóstico , Polirradiculoneuropatia/terapia , Trombose/diagnóstico , Trombose/terapia
3.
Brain Dev ; 32(10): 872-8, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20060673

RESUMO

UNLABELLED: Propofol is a widely used hypnotic agent for induction and maintenance of pediatric anesthesia with a well known safety profile. Experimental in vitro studies suggest that propofol may be toxic to developing neurons. We report the cases of three infants who underwent surgery before 2 months of age for different benign pathologies. Propofol was used for induction and maintenance of anesthesia in all cases. The three patients developed convulsions with similar clinical characteristics (cluster of recurrent clinical and subclinical seizures) between the 23th and 30th hours following anesthesia. Clinical and electroencephalographic improvement was obtained between the third and fourth day of management in pediatric intensive care unit. The seizures never recurred, and the three patients underwent further uneventful general anesthesia without propofol. Follow-up of the three patients disclosed unexpected neurological dysfunction: progressive microcephaly (head circumferences were normal at birth), developmental impairment with cognitive and behavioural disturbances in two cases, and bilateral symmetrical white-matter abnormalities on cerebral magnetic resonance imaging. CONCLUSION: The causal relationship between propofol anesthesia and the neurological symptoms of our patients remains difficult to ascertain, but we believe that pediatricians, anesthetists and intensive care-givers should be aware of this possible adverse reaction that has never been described before.


Assuntos
Anestesia Intravenosa/efeitos adversos , Anestésicos Intravenosos/efeitos adversos , Síndromes Neurotóxicas/fisiopatologia , Propofol/efeitos adversos , Anticonvulsivantes/uso terapêutico , Encéfalo/patologia , Catarata/congênito , Extração de Catarata , Cavidades Cranianas/anormalidades , Cavidades Cranianas/cirurgia , Deficiências do Desenvolvimento/induzido quimicamente , Eletroencefalografia , Epilepsia Tônico-Clônica/etiologia , Epilepsia Tônico-Clônica/fisiopatologia , Feminino , Cabeça/anatomia & histologia , Hérnia Inguinal/cirurgia , Humanos , Lactente , Transtornos do Desenvolvimento da Linguagem , Imageamento por Ressonância Magnética , Microcefalia/induzido quimicamente , Microcefalia/patologia , Testes Neuropsicológicos , Síndromes Neurotóxicas/patologia , Convulsões/induzido quimicamente , Convulsões/tratamento farmacológico
4.
Arch Pediatr ; 14(2): 187-93, 2007 Feb.
Artigo em Francês | MEDLINE | ID: mdl-17137769

RESUMO

Paroxysmal movement disorders are not uncommon in childhood, but are probably under-recognised. Paroxysmal movement disorders are a distinctive group of disorders that represents various clinical situations, characterised by intermittent and episodic disturbances of movement. Diagnosis relies on semiological analysis, mainly based on parental description of the manifestations; video recording (during an EEG-video monitoring or home made video) are often helpful to establish the correct diagnosis. In the large majority of the cases, paroxysmal movement disorders are benign situations. Some of them are transient, as they spontaneously stop over time (benign torticolis of infancy, paroxysmal tonic upgaze). Being familiar with these disorders will lead to accurate diagnosis, so avoiding useless investigations. Most of the time, no treatment will be required, and the families will be informed of the good prognosis.


Assuntos
Transtornos dos Movimentos/fisiopatologia , Criança , Diagnóstico Diferencial , Eletroencefalografia , Epilepsia , Humanos , Monitorização Fisiológica , Transtornos dos Movimentos/classificação , Transtornos dos Movimentos/etiologia , Remissão Espontânea
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...